Aspiriant LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$354K Sell
7,653
-76
-1% -$3.52K 0.01% 232
2025
Q1
$471K Buy
7,729
+157
+2% +$9.58K 0.02% 194
2024
Q4
$428K Sell
7,572
-520
-6% -$29.4K 0.02% 202
2024
Q3
$419K Buy
8,092
+1,303
+19% +$67.4K 0.02% 200
2024
Q2
$282K Sell
6,789
-2,329
-26% -$96.7K 0.01% 237
2024
Q1
$495K Buy
9,118
+702
+8% +$38.1K 0.02% 199
2023
Q4
$432K Buy
8,416
+849
+11% +$43.6K 0.02% 203
2023
Q3
$439K Sell
7,567
-6,054
-44% -$351K 0.02% 192
2023
Q2
$871K Sell
13,621
-736
-5% -$47.1K 0.04% 146
2023
Q1
$995K Sell
14,357
-50
-0.3% -$3.47K 0.05% 132
2022
Q4
$1.04M Buy
14,407
+1,388
+11% +$99.9K 0.05% 129
2022
Q3
$925K Buy
13,019
+111
+0.9% +$7.89K 0.05% 127
2022
Q2
$995K Buy
12,908
+2,707
+27% +$209K 0.05% 122
2022
Q1
$745K Sell
10,201
-1,881
-16% -$137K 0.04% 149
2021
Q4
$753K Buy
12,082
+4,424
+58% +$276K 0.04% 154
2021
Q3
$453K Sell
7,658
-125
-2% -$7.39K 0.03% 168
2021
Q2
$519K Buy
7,783
+69
+0.9% +$4.6K 0.03% 157
2021
Q1
$487K Buy
7,714
+890
+13% +$56.2K 0.03% 150
2020
Q4
$422K Buy
6,824
+372
+6% +$23K 0.03% 154
2020
Q3
$390K Buy
6,452
+29
+0.5% +$1.75K 0.03% 166
2020
Q2
$377K Sell
6,423
-394
-6% -$23.1K 0.04% 146
2020
Q1
$381K Sell
6,817
-10
-0.1% -$559 0.04% 142
2019
Q4
$440K Buy
6,827
+724
+12% +$46.7K 0.04% 147
2019
Q3
$312K Sell
6,103
-327
-5% -$16.7K 0.03% 176
2019
Q2
$291K Sell
6,430
-1,607
-20% -$72.7K 0.02% 180
2019
Q1
$382K Sell
8,037
-541
-6% -$25.7K 0.03% 165
2018
Q4
$447K Sell
8,578
-1,176
-12% -$61.3K 0.03% 151
2018
Q3
$605K Sell
9,754
-4,694
-32% -$291K 0.05% 144
2018
Q2
$800K Sell
14,448
-6,845
-32% -$379K 0.07% 123
2018
Q1
$1.35M Buy
+21,293
New +$1.35M 0.12% 88
2017
Q4
Sell
-15,340
Closed -$978K 94
2017
Q3
$978K Sell
15,340
-1,968
-11% -$125K 0.08% 107
2017
Q2
$964K Buy
17,308
+676
+4% +$37.7K 0.08% 116
2017
Q1
$905K Buy
+16,632
New +$905K 0.08% 121